Trial Profile
A Post Marketing surveillance study on the safety ad efficacy of the GreenGene F in patients with haemophilia A
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2017
Price :
$35
*
At a glance
- Drugs Beroctocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions; Therapeutic Use
- 01 Jan 2018 Results published in the Journal of Korean Medical Science
- 10 Sep 2016 New trial record